Fluoroscopy and C-Arm Market to Surpass USD 5.71 Bn by 2031

Global Fluoroscopy and C-Arm Market Is Estimated to Witness High Growth Owing to Rising Chronic Diseases Prevalence and Growing Geriatric Population

The Global Fluoroscopy and C-Arm Market is estimated to be valued at USD 4.10 Bn in 2024, exhibiting a CAGR of 4.8% over the forecast period (2024-2031). The rising prevalence of chronic diseases such as cardiovascular diseases, cancer, and gastrointestinal disorders coupled with growing geriatric population are expected to propel the market growth. Furthermore, technological advancements in fluoroscopy devices resulting in highly advanced and accurate imaging are also augmenting the market expansion.

Market Dynamics:

The growth of the global fluoroscopy and C-arm market is driven by the rising prevalence of chronic diseases as well as the growing geriatric population globally. As per the WHO, chronic diseases accounted for approximately 60% of the total reported deaths in 2020. The growing incidence of chronic illnesses, such as cardiovascular diseases and cancer, has heightened the need for advanced imaging procedures including fluoroscopy and C-arm imaging. This is expected to significantly drive the demand for fluoroscopy and C-arm devices. Additionally, the rising pool of elderly population who are more prone to chronic conditions will further fuel the market growth over the forecast period.

Increasing Demand for Minimally Invasive Surgeries is Driving the Market Growth

The global fluoroscopy and C-arm market is witnessing significant growth due to the rising demand for minimally invasive surgeries. Minimally invasive procedures require the use of fluoroscopy and C-arms for visualization during surgery. They offer benefits like smaller incisions, lesser pain, quicker recovery time, and reduced scarring compared to traditional open surgeries. As such, the demand for these procedures is increasing globally. This is directly increasing the demand for fluoroscopy and C-arm devices which help surgeons perform complex minimally invasive surgeries with ease and precision. Various factors like growing geriatric population suffering from orthopedic problems and rising lifestyle disease prevalence are further augmenting the demand for minimally invasive surgeries worldwide.

Increasing Number of Trauma and Accident Cases is Fueling Market Growth

Road accidents and injury cases have increased manifold globally. Trauma and accident victims require urgent surgeries like fracture fixations which commonly use fluoroscopy-guided procedures. The growing road accident fatalities and trauma injuries are presenting significant growth opportunities for players in the fluoroscopy and C-arm market. These devices help surgeons efficiently treat fractures and injuries in trauma/accident cases. With rapid urbanization and industrialization worldwide, the risks of accidents and physical injuries have risen substantially. This is directly supplementing the demand for fluoroscopy and C-arm systems from trauma and emergency centers.

High Cost of Systems is Limiting Adoption in Price-Sensitive Regions

One of the major restraints faced by the fluoroscopy and C-arm market is the high cost of these surgical imaging systems. Advanced C-arms with flat panel detectors and the latest imaging software come at a very high price which is difficult for budget-constrained public hospitals and centers in developing nations to afford. This hampers the widespread adoption of these life-saving devices, especially in price-sensitive regions. The high capital requirement and other maintenance costs associated with fluoroscopy and C-arm devices are restricting their demand from cost-cautious end-users. While developed countries have sufficient healthcare budgets, many developing countries grapple with limited resources which restrict market growth.

Regulatory Compliance Issues Delay New Product Launches

Stringent regulatory compliance norms in the medical device industry also act as a market barrier. Getting regulatory approvals for new fluoroscopy and C-arm device designs and features takes a significant amount of time and money. Clinical trials and devices certification processes involve huge costs. This discourages continuous product innovation and delays new product launches. Frequent modifications in regulatory guidelines by bodies like the U.S. FDA further extend approval timelines. The tough compliance environment extends the product development cycles, restricting frequent product launches. This is a major roadblock especially for small medical device manufacturers. The heavy regulatory frameworks continue limiting business agility and faster market proliferation.

Expanding Healthcare Infrastructure Widens Growth Avenues

Fluoroscopy and C-arm markets in emerging countries present massive growth potential as their healthcare infrastructure strengthens. Governments in developing nations are rigorously investing in healthcare access expansion through public-private partnerships. This is resulting in the development of new hospitals, clinics, and ambulatory surgical centers. The augmenting clinical facilities offer abundant opportunities for market players to increase product penetration. Additionally, favorable regulatory reforms and funding programs make advanced surgical devices more affordable for price-sensitive nations. With universal healthcare becoming a global priority, investments into medical technologies will rise multifold across developing regions in the coming years. This presents lucrative growth prospects for companies in the fluoroscopy and C-arm domain.

Rising Medical Tourism Promotes Adoption

The burgeoning medical tourism industry is opening new avenues for fluoroscopy and C-arm providers. People from developed nations are increasingly travelling to low-cost yet high-quality destinations in Asia and Latin America for surgical procedures. This has amplified the demand for state-of-the-art operating room equipment like fluoroscopy and C-arms worldwide. Moreover, growing awareness about the benefits of minimally invasive surgeries is accelerating medical tourism in orthopedic and cardiac segments. The mushrooming multi-specialty hospitals catering to international patients require advanced imaging systems. The robust expansion of overseas patient inflows will continue raising installation volumes of these devices across key medical tourism destinations.

Link: https://www.coherentmarketinsights.com/market-insight/fluoroscopy-and-c-arm-market-510

Key Developments:

• In November 2024, Augmedics, a developer of an augmented-reality surgical visualization system, announced the USFDA 510(k) clearance for its new CT-to-fluoroscopy (CT-Fluoro) registration method for the xvision Spine System, enabling AR navigation with preoperative CT scans and standard 2D C-arm images, eliminating the need for 3D intraoperative imaging. The first surgery using this method was successfully performed by Dr. Frank Phillips at Rush University Medical Center, highlighting its potential to expand AR navigation access for spine surgeons.
• In November 2024, GE HealthCare, a global medical technology, introduced advanced imaging innovations for its OEC 3D mobile CBCT C-arm, enhancing precision and workflow in interventional pulmonology. The addition of the Lung Suite and expanded third-party data interface options streamline imaging during endoscopic bronchoscopy procedures, helping clinicians accurately locate and biopsy lung nodules despite challenges like respiratory pattern changes and CT-to-body divergence. These advancements aim to improve diagnostic confidence and efficiency in complex pulmonary and thoracic procedures.
• In March 2024, Siemens Healthineers, a healthcare company, received the U.S. FDA clearance for the CIARTIC Move, a self-driving mobile C-arm that streamlines 2D fluoroscopic and 3D cone-beam CT imaging for surgeries. Designed for orthopedic, trauma, spine, and other procedures, it automates workflows, reduces imaging time, and supports overtaxed operating room teams. This innovation marks Siemens’ first self-driving mobile C-arm, enhancing efficiency in hospitals and outpatient facilities.
• In July 2022, FUJIFILM Healthcare Americas Corporation, a leading innovator in diagnostic and enterprise imaging solutions, launched the FDR Cross in the U.S., an innovative hybrid C-arm and portable X-ray system designed for hospitals and ambulatory surgery centers. This dual-function system combines fluoroscopic and radiographic imaging on a single platform, streamlining workflows, and improving patient care. According to Rob Fabrizio, the FDR Cross enhances equipment efficiency by enabling multiple imaging functions with one device.

Key Players:

General Electric Company, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Canon Medical Systems Corporation, Shimadzu Corporation, Carestream Health, Hitachi, Ltd., Hologic, Inc., Varex Imaging Corporation, Ziehm Imaging GmbH, OrthoScan, Inc., Varian Medical Systems, Inc., DMS Group, ITALRAY, and Nova Biomedical